FDA approves GlaxoSmithKline's HPV vaccine.
Cervarix is designed to help prevent cervical cancer.
Drug will compete with another HPV vaccine Merck & Company's Gardasil.
Cervarix will be available later this year, according to GlaxoSmithKline.
